Specific Thiazolidinediones Inhibit Ovarian Cancer Cell Line Proliferation and Cause Cell Cycle Arrest in a PPARγ Independent Manner

BACKGROUND: Peroxisome Proliferator Activated Receptor gamma (PPARγ) agonists, such as the thiazolinediones (TZDs), have been studied for their potential use as cancer therapeutic agents. We investigated the effect of four TZDs—Rosiglitazone (Rosi), Ciglitazone (CGZ), Troglitazone (TGZ), and Pioglit...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Alem, Linah, Southard, R. Chase, Kilgore, Michael W., Curry, Thomas E.
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3025024/
https://www.ncbi.nlm.nih.gov/pubmed/21283708
http://dx.doi.org/10.1371/journal.pone.0016179

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3025024/
https://www.ncbi.nlm.nih.gov/pubmed/21283708
http://dx.doi.org/10.1371/journal.pone.0016179

Ejemplares similares